11 Jan 2019 Research

Myelofibrosis: Finding new ways to treat patients

Myelofibrosis is a fatal bone marrow cancer. The disease is caused by excessive secretion of factors by cancerous platelet-producing cells called megakaryocytes. These secretions cause the replacement of normal bone marrow tissue with fibrous scar tissue.

Dr Chen’s team can successfully recreate this pathological bone marrow environment in the laboratory, and their preliminary research data shows that reduced levels of a protein complex called FANCcore leads to more myelofibrosis.

Dr Chen’s team hypothesise that loss of the protein complex FANCcore increases the growth of myelfibrosis by altering megakaryocytes. Dr Chen uses both human tissue cultures and mouse models to examine the cellular and molecular changes to megakaryocytes following the absence of the FANCcore complex and to understand how these changes cause myelofibrosis.

The team hopes that by focusing on the role of FANCcore in megakaryocyte biology, they can reveal new ways to treat myelofibrosis.

Related posts

MP opens Leukaemia UK Ambulatory Care Unit

15 June 2018

MP opens Leukaemia UK Ambulatory Care Unit

A unit funded by Leukaemia UK which allows people with blood cancer to have stem cell transplants as out-patients has been officially opened by its first patient, Nick Boles MP

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

25 November 2025

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

Today, NICE announced its recommendation for Aucatzyl (obecabtagene autoleucel), a CAR-T therapy, to be made available on the NHS for treating adults aged 26 and over with relapsed or refractory…

“Leukaemia changes everyone’s life.”: Chris Corbin OBE announced as a Leukaemia UK patron

30 January 2025

“Leukaemia changes everyone’s life.”: Chris Corbin OBE announced as a Leukaemia UK patron

The renowned restauranteur Chris Corbin OBE has been announced as a patron for blood cancer charity Leukaemia UK. Coinciding with the 30th anniversary of the stem cell transplant which saved…

Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy

31 October 2022

Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy

Blood cancer research charity, Leukaemia UK, has hired Anna Wilson and Lizzie Afonso from housing and homelessness charity, Shelter, to job-share its new Communications Director role. This is the first…